chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Illness, Myalgia
Clinical narrative: fatigue, described as being exhausted; headache; muscle pain; joint pain everywhere; being nauseous and vomiting; fever; tightening of her throat, described as it felt like someone was squeezing her throat; has been so sick and can't seem to stay out of bed; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (tightening of her throat, described as it felt like someone was squeezing her throat), ILLNESS (has been so sick and can't seem to stay out of bed), FATIGUE (fatigue, described as being exhausted), HEADACHE (headache) and MYALGIA (muscle pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SERTRALINE and LAMOTRIGINE (LAMICTAL) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (tightening of her throat, described as it felt like someone was squeezing her throat) and ILLNESS (has been so sick and can't seem to stay out of bed). On 02-Apr-2021, the patient experienced FATIGUE (fatigue, described as being exhausted), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain everywhere), VOMITING (being nauseous and vomiting) and PYREXIA (fever). At the time of the report, OROPHARYNGEAL DISCOMFORT (tightening of her throat, described as it felt like someone was squeezing her throat), ILLNESS (has been so sick and can't seem to stay out of bed), FATIGUE (fatigue, described as being exhausted), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain everywhere), VOMITING (being nauseous and vomiting) and PYREXIA (fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment drug used was Pepto-Bismol (Bismuth subsalicylate)
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Pyrexia, Vomiting
Clinical narrative: fatigue, described as being exhausted; headache; muscle pain; joint pain everywhere; being nauseous and vomiting; fever; tightening of her throat, described as it felt like someone was squeezing her throat; has been so sick and can't seem to stay out of bed; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (tightening of her throat, described as it felt like someone was squeezing her throat), ILLNESS (has been so sick and can't seem to stay out of bed), FATIGUE (fatigue, described as being exhausted), HEADACHE (headache) and MYALGIA (muscle pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SERTRALINE and LAMOTRIGINE (LAMICTAL) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (tightening of her throat, described as it felt like someone was squeezing her throat) and ILLNESS (has been so sick and can't seem to stay out of bed). On 02-Apr-2021, the patient experienced FATIGUE (fatigue, described as being exhausted), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain everywhere), VOMITING (being nauseous and vomiting) and PYREXIA (fever). At the time of the report, OROPHARYNGEAL DISCOMFORT (tightening of her throat, described as it felt like someone was squeezing her throat), ILLNESS (has been so sick and can't seem to stay out of bed), FATIGUE (fatigue, described as being exhausted), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain everywhere), VOMITING (being nauseous and vomiting) and PYREXIA (fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment drug used was Pepto-Bismol (Bismuth subsalicylate)
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Urinary Tract Infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Urinary Tract Infection) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 14-Mar-2021, the patient experienced URINARY TRACT INFECTION (Urinary Tract Infection). The patient was treated with CIPROFLOXACIN on 15-Mar-2021 at a dose of 500 milligram twice a day and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 25-Mar-2021, URINARY TRACT INFECTION (Urinary Tract Infection) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient took Gatorade,Pedialyte and Water along with other concomitant medications.   This case was linked to US-MODERNATX, INC.-MOD-2021-068605 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068605:MOD-2021-068605 -2nd dose of vaccine
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Fatigue, Feeling abnormal
Clinical narrative: brain fog is still present; short term memory loss ( 4days long); fatigue that lasted for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (brain fog is still present), AMNESIA (short term memory loss ( 4days long)) and FATIGUE (fatigue that lasted for 3 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (brain fog is still present), AMNESIA (short term memory loss ( 4days long)) and FATIGUE (fatigue that lasted for 3 days). At the time of the report, FEELING ABNORMAL (brain fog is still present) had not resolved and AMNESIA (short term memory loss ( 4days long)) and FATIGUE (fatigue that lasted for 3 days) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.     Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow up received on 25JUN2021, updated Reporter information and patient stated that she didn't get her 2nd shot and Action taken was updated.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed her second dose appointment which was scheduled to be on 23March2021; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed her second dose appointment which was scheduled to be on 23March2021) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed her second dose appointment which was scheduled to be on 23March2021). On 23-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Missed her second dose appointment which was scheduled to be on 23March2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.    This case was linked to MODERNATX, INC.-MOD-2021-068984 (E2B Linked Report).; Reporter's Comments: This report refers to a case of missed dose( patient did not receive second dose) for mRNA- 1273, ( batch # 024M20A) with no associated AEs; Sender's Comments:  MODERNATX, INC.-MOD-2021-068984:husband case
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Rash macular
Clinical narrative: Few small red blotches; Red spots on the torso front.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH MACULAR (Few small red blotches) and RASH ERYTHEMATOUS (Red spots on the torso front.) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (reactions include hives, throat tightening), Sulfonamide allergy (sulfa drugs reactions include throat tightening), Drug allergy (Most Anti-inflammatories), Fruit allergy (Kiwi fruit reactions include hives, throat tightening), Drug allergy (Kafflex reactions include throat tightening) and Urticaria. Concomitant products included METOPROLOL TARTRATE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 09-Feb-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red spots on the torso front.). On 02-Mar-2021, the patient experienced RASH MACULAR (Few small red blotches). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Few small red blotches) and RASH ERYTHEMATOUS (Red spots on the torso front.) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       This case was linked toMOD-2021-068561 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Patient details updated On 14-Jun-2021: Patient demographics were updated,Medical history includes Allergies were updated,Concomitant product information was updated Event Red spots on torso outcome was updated from Unknown to Not recovered On 22-Jun-2021: Follow-up information received on 22-Jun-2021 contains no new information On 22-Jun-2021: Follow-up information received on 22-Jun-2021 contains no significant information On 22-Jun-2021: Medical history added, date of lab data updated
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itchy at injection site; little red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (little red at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (little red at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy at injection site) and VACCINATION SITE ERYTHEMA (little red at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Balance disorder, Headache, Malaise, Pain
Clinical narrative: equilibrium seem to be a little bit of balance; nose is running; Stomach is loose; didnt feel good; could not raise his arm over his shoulder last night; experienced a lot of pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (equilibrium seem to be a little bit of balance), RHINORRHOEA (nose is running), ABDOMINAL DISCOMFORT (Stomach is loose), MALAISE (didnt feel good) and VACCINATION SITE MOVEMENT IMPAIRMENT (could not raise his arm over his shoulder last night) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 00FBZ1A and 036A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 05-Apr-2021, the patient experienced BALANCE DISORDER (equilibrium seem to be a little bit of balance), RHINORRHOEA (nose is running), ABDOMINAL DISCOMFORT (Stomach is loose), MALAISE (didnt feel good), VACCINATION SITE MOVEMENT IMPAIRMENT (could not raise his arm over his shoulder last night), PAIN (experienced a lot of pain) and HEADACHE (Headache). At the time of the report, BALANCE DISORDER (equilibrium seem to be a little bit of balance), RHINORRHOEA (nose is running), ABDOMINAL DISCOMFORT (Stomach is loose), MALAISE (didnt feel good), VACCINATION SITE MOVEMENT IMPAIRMENT (could not raise his arm over his shoulder last night), PAIN (experienced a lot of pain) and HEADACHE (Headache) outcome was unknown.            No concomitant drugs. Treatment included Dayquil. Consent for safety to follow-up was received, preferably via phone
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, Vaccination site movement impairment
Clinical narrative: equilibrium seem to be a little bit of balance; nose is running; Stomach is loose; didnt feel good; could not raise his arm over his shoulder last night; experienced a lot of pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (equilibrium seem to be a little bit of balance), RHINORRHOEA (nose is running), ABDOMINAL DISCOMFORT (Stomach is loose), MALAISE (didnt feel good) and VACCINATION SITE MOVEMENT IMPAIRMENT (could not raise his arm over his shoulder last night) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 00FBZ1A and 036A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 05-Apr-2021, the patient experienced BALANCE DISORDER (equilibrium seem to be a little bit of balance), RHINORRHOEA (nose is running), ABDOMINAL DISCOMFORT (Stomach is loose), MALAISE (didnt feel good), VACCINATION SITE MOVEMENT IMPAIRMENT (could not raise his arm over his shoulder last night), PAIN (experienced a lot of pain) and HEADACHE (Headache). At the time of the report, BALANCE DISORDER (equilibrium seem to be a little bit of balance), RHINORRHOEA (nose is running), ABDOMINAL DISCOMFORT (Stomach is loose), MALAISE (didnt feel good), VACCINATION SITE MOVEMENT IMPAIRMENT (could not raise his arm over his shoulder last night), PAIN (experienced a lot of pain) and HEADACHE (Headache) outcome was unknown.            No concomitant drugs. Treatment included Dayquil. Consent for safety to follow-up was received, preferably via phone
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site swelling
Clinical narrative: Sore arm; Swollen like marble; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE SWELLING (Swollen like marble) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE SWELLING (Swollen like marble). At the time of the report, PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE SWELLING (Swollen like marble) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications are provided. The reporter patient have blood drawn appointment for regular check-up on 12 Apr 2021. Patient questioned if vaccination is going to affect the blood work.   This case was linked to US-MODERNATX, INC.-MOD-2021-068611 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068611:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain, Chills, Dyspnoea
Clinical narrative: Extreme pain in abdomen; Bloated stomach; Trouble breathing; pain started in her right side and went across her left side,in so much pain that she could hardly let the examiners touch her gut; chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Extreme pain in abdomen), ABDOMINAL DISTENSION (Bloated stomach), DYSPNOEA (Trouble breathing), CHILLS (chills) and ABDOMINAL PAIN (pain started in her right side and went across her left side,in so much pain that she could hardly let the examiners touch her gut) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 639A2A1) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced CHILLS (chills). On 04-Apr-2021, the patient experienced ABDOMINAL PAIN (Extreme pain in abdomen), ABDOMINAL DISTENSION (Bloated stomach), DYSPNOEA (Trouble breathing) and ABDOMINAL PAIN (pain started in her right side and went across her left side,in so much pain that she could hardly let the examiners touch her gut). On 04-Apr-2021, ABDOMINAL DISTENSION (Bloated stomach), DYSPNOEA (Trouble breathing) and ABDOMINAL PAIN (pain started in her right side and went across her left side,in so much pain that she could hardly let the examiners touch her gut) had resolved. At the time of the report, ABDOMINAL PAIN (Extreme pain in abdomen) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Lab data: Vitals, X-ray and CT scan were normal   This case was linked to MOD-2021-183282 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Condition aggravated, Dizziness, Feeling abnormal, Headache
Clinical narrative: stomach pain; symptoms have increased after I got the shot.; I'm not feeling good; slight headache; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ABDOMINAL PAIN UPPER (stomach pain), CONDITION AGGRAVATED (symptoms have increased after I got the shot.), FEELING ABNORMAL (I'm not feeling good) and HEADACHE (slight headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Schizophrenia (Bipolar). Concomitant products included VALPROATE SEMISODIUM (DIVALPROEX) for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (dizziness), ABDOMINAL PAIN UPPER (stomach pain), CONDITION AGGRAVATED (symptoms have increased after I got the shot.), FEELING ABNORMAL (I'm not feeling good) and HEADACHE (slight headache). At the time of the report, DIZZINESS (dizziness), ABDOMINAL PAIN UPPER (stomach pain), CONDITION AGGRAVATED (symptoms have increased after I got the shot.), FEELING ABNORMAL (I'm not feeling good) and HEADACHE (slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 22-year-old female patient (gravida 4, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 046A21A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy on 19-Jul-2017 and Spontaneous abortion (Patient had 3 previous pregnancies and had 2 spontaneous abortion). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 10-Feb-2021 and the estimated date of delivery was 16-Oct-2021. On 06-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  third week of the pregnancy.  On 06-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Pregnancy test: positive (Positive) Positive.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: got Covid Infection after receiving the Moderna vaccine 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got Covid Infection after receiving the Moderna vaccine 1st dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got Covid Infection after receiving the Moderna vaccine 1st dose). At the time of the report, COVID-19 (got Covid Infection after receiving the Moderna vaccine 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Gingival swelling, Pyrexia
Clinical narrative: Swollen gums/blisters; Fatigue; Fever; Chills; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), GINGIVAL SWELLING (Swollen gums/blisters), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (Chills) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0088B21-21A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced DIZZINESS (Dizziness), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (Chills). On 04-Apr-2021, the patient experienced GINGIVAL SWELLING (Swollen gums/blisters). On 09-Apr-2021, DIZZINESS (Dizziness), GINGIVAL SWELLING (Swollen gums/blisters), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (Chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included gargling salt and water.   This case was linked to MOD-2021-245545 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow-up received updated outcome of events and patient details.
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Lip swelling
Clinical narrative: swollen upper lip; dry mouth; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swollen upper lip) and DRY MOUTH (dry mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIP SWELLING (swollen upper lip) and DRY MOUTH (dry mouth). At the time of the report, LIP SWELLING (swollen upper lip) and DRY MOUTH (dry mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: was not able to receive his second dose within standard time frame; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (was not able to receive his second dose within standard time frame) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (was not able to receive his second dose within standard time frame). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (was not able to receive his second dose within standard time frame) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Pyrexia
Clinical narrative: Sweating; Chills; Fever (100°F); This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), CHILLS (Chills) and PYREXIA (Fever (100°F)) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating), CHILLS (Chills) and PYREXIA (Fever (100°F)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating), CHILLS (Chills) and PYREXIA (Fever (100°F)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication provided.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Electric shock sensation, Influenza like illness, Ocular hyperaemia, Product administered to patient of inappropriate age
Clinical narrative: Redness on his eyes; Flu-like symptoms; Chills; 17 year old receiving vaccine; Electric shock through all his body as soon as he had the injection; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old receiving vaccine), ELECTRIC SHOCK SENSATION (Electric shock through all his body as soon as he had the injection), OCULAR HYPERAEMIA (Redness on his eyes), INFLUENZA LIKE ILLNESS (Flu-like symptoms) and CHILLS (Chills) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old receiving vaccine) and ELECTRIC SHOCK SENSATION (Electric shock through all his body as soon as he had the injection). On 06-Apr-2021, the patient experienced OCULAR HYPERAEMIA (Redness on his eyes), INFLUENZA LIKE ILLNESS (Flu-like symptoms) and CHILLS (Chills). On 30-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old receiving vaccine) and ELECTRIC SHOCK SENSATION (Electric shock through all his body as soon as he had the injection) had resolved. At the time of the report, OCULAR HYPERAEMIA (Redness on his eyes), INFLUENZA LIKE ILLNESS (Flu-like symptoms) and CHILLS (Chills) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Hyperhidrosis, Nausea
Clinical narrative: Tired; Diarrhea; Sweat on forehead; Nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (Diarrhea), NAUSEA (Nausea), HYPERHIDROSIS (Sweat on forehead) and FATIGUE (Tired) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 011A21A)) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), NAUSEA (Nausea) and HYPERHIDROSIS (Sweat on forehead). On 01-Apr-2021, the patient experienced FATIGUE (Tired). On 04-Apr-2021, DIARRHOEA (Diarrhea), NAUSEA (Nausea) and HYPERHIDROSIS (Sweat on forehead) had resolved. At the time of the report, FATIGUE (Tired) outcome was unknown. Not Provided          concomitant  drug : Blood Pressure Medication treatment drugs  : Ciprofloxacin 500mg BID X 10 Days Started on 15MAR2021 Tylenol Gatorade Pedialyte Water   This case was linked to MOD21-070095 (E2B Linked Report).; Sender's Comments:  MOD21-070095:MOD-2021-068586 -1st dose of Vaccine US-MODERNATX, INC.-MOD-2021-068586:MOD-2021-068605 -2nd dose of vaccine
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus, Rash, Sensitive skin
Clinical narrative: severe itching; very severe rash on both arms, neck, and chest; started breaking a rash with blisters; tingling in arms and legs; skin was sensitive to the water of the shower; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in arms and legs), SENSITIVE SKIN (skin was sensitive to the water of the shower), PRURITUS (severe itching), RASH (started breaking a rash with blisters) and RASH (very severe rash on both arms, neck, and chest) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) Injection. On 01-Mar-2021, the patient experienced PARAESTHESIA (tingling in arms and legs), SENSITIVE SKIN (skin was sensitive to the water of the shower) and RASH (started breaking a rash with blisters). On 02-Mar-2021, the patient experienced PRURITUS (severe itching) and RASH (very severe rash on both arms, neck, and chest). On 01-Apr-2021, PARAESTHESIA (tingling in arms and legs), SENSITIVE SKIN (skin was sensitive to the water of the shower), PRURITUS (severe itching), RASH (started breaking a rash with blisters) and RASH (very severe rash on both arms, neck, and chest) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Muscle spasms, Pain in extremity
Clinical narrative: muscle spasm; sore arm; sore back; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), BACK PAIN (sore back) and MUSCLE SPASMS (muscle spasm ) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL, PROPRANOLOL HYDROCHLORIDE (PROPANOLOL BOEHRINGER), AMLODIPINE and METFORMIN for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and BACK PAIN (sore back). On 04-Apr-2021, the patient experienced MUSCLE SPASMS (muscle spasm ). On 03-Apr-2021, PAIN IN EXTREMITY (sore arm) and BACK PAIN (sore back) had resolved. At the time of the report, MUSCLE SPASMS (muscle spasm ) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not included.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Product use issue, Pyrexia
Clinical narrative: Product use at inappropriate site; Movements reduced; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT USE ISSUE (Product use at inappropriate site), PYREXIA (Fever) and HYPOKINESIA (Movements reduced) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not reported.).   On 04-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced PRODUCT USE ISSUE (Product use at inappropriate site). On an unknown date, the patient experienced PYREXIA (Fever) and HYPOKINESIA (Movements reduced). On 04-Apr-2021, PRODUCT USE ISSUE (Product use at inappropriate site) had resolved. At the time of the report, PYREXIA (Fever) and HYPOKINESIA (Movements reduced) outcome was unknown.            Concomitant medication use was not provided. Treatment information included arm treated with hot showers.. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure increased, Headache, Pain
Clinical narrative: headaches on and off; blood pressure was elevated; soreness; pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches on and off), BLOOD PRESSURE INCREASED (blood pressure was elevated), ARTHRALGIA (soreness) and PAIN (pain) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches on and off), BLOOD PRESSURE INCREASED (blood pressure was elevated), ARTHRALGIA (soreness) and PAIN (pain). At the time of the report, HEADACHE (headaches on and off), BLOOD PRESSURE INCREASED (blood pressure was elevated), ARTHRALGIA (soreness) and PAIN (pain) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-068619 (E2B Linked Report).; Sender's Comments:  MOD-2021-068619:Second dose of vaccine case.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: dizzy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) and DIZZINESS (dizzy) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (not reported).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired) and DIZZINESS (dizzy). At the time of the report, FATIGUE (Tired) and DIZZINESS (dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-068593 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068593:
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Myalgia, Neuralgia, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling throughout the body), SKIN BURNING SENSATION (Burning throughout the body), NEURALGIA (Nerve pain throughout the body), DIZZINESS (dizziness) and PAIN IN EXTREMITY (Pain in her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   No medical history was reported by the reporter.     On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PARAESTHESIA (tingling throughout the body), SKIN BURNING SENSATION (Burning throughout the body), NEURALGIA (Nerve pain throughout the body), DIZZINESS (dizziness), PAIN IN EXTREMITY (Pain in her arm), PAIN IN EXTREMITY (Pain in legs), HEADACHE (headache) and MYALGIA (Muscle pain throught the body). The patient was treated with IBUPROFEN for Headache and Dizziness, at an unspecified dose and frequency. On 25-Mar-2021, DIZZINESS (dizziness), PAIN IN EXTREMITY (Pain in her arm), PAIN IN EXTREMITY (Pain in legs) and HEADACHE (headache) had resolved. At the time of the report, PARAESTHESIA (tingling throughout the body), SKIN BURNING SENSATION (Burning throughout the body), NEURALGIA (Nerve pain throughout the body) and MYALGIA (Muscle pain throught the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included ibuprofen.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Skin burning sensation
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling throughout the body), SKIN BURNING SENSATION (Burning throughout the body), NEURALGIA (Nerve pain throughout the body), DIZZINESS (dizziness) and PAIN IN EXTREMITY (Pain in her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   No medical history was reported by the reporter.     On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PARAESTHESIA (tingling throughout the body), SKIN BURNING SENSATION (Burning throughout the body), NEURALGIA (Nerve pain throughout the body), DIZZINESS (dizziness), PAIN IN EXTREMITY (Pain in her arm), PAIN IN EXTREMITY (Pain in legs), HEADACHE (headache) and MYALGIA (Muscle pain throught the body). The patient was treated with IBUPROFEN for Headache and Dizziness, at an unspecified dose and frequency. On 25-Mar-2021, DIZZINESS (dizziness), PAIN IN EXTREMITY (Pain in her arm), PAIN IN EXTREMITY (Pain in legs) and HEADACHE (headache) had resolved. At the time of the report, PARAESTHESIA (tingling throughout the body), SKIN BURNING SENSATION (Burning throughout the body), NEURALGIA (Nerve pain throughout the body) and MYALGIA (Muscle pain throught the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication included ibuprofen.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Eye pain, Feeling abnormal
Clinical narrative: eyes hurt; sees blurred; body felt weird; pain; chills; headache; very dizzy; weak; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very dizzy), ASTHENIA (weak), EYE PAIN (eyes hurt), VISION BLURRED (sees blurred) and HEADACHE (headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced DIZZINESS (very dizzy) and ASTHENIA (weak). On 06-Apr-2021, the patient experienced EYE PAIN (eyes hurt), VISION BLURRED (sees blurred), HEADACHE (headache), CHILLS (chills), FEELING ABNORMAL (body felt weird) and PAIN (pain). At the time of the report, DIZZINESS (very dizzy), ASTHENIA (weak), EYE PAIN (eyes hurt), VISION BLURRED (sees blurred), HEADACHE (headache), CHILLS (chills), FEELING ABNORMAL (body felt weird) and PAIN (pain) outcome was unknown.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Vision blurred
Clinical narrative: eyes hurt; sees blurred; body felt weird; pain; chills; headache; very dizzy; weak; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very dizzy), ASTHENIA (weak), EYE PAIN (eyes hurt), VISION BLURRED (sees blurred) and HEADACHE (headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced DIZZINESS (very dizzy) and ASTHENIA (weak). On 06-Apr-2021, the patient experienced EYE PAIN (eyes hurt), VISION BLURRED (sees blurred), HEADACHE (headache), CHILLS (chills), FEELING ABNORMAL (body felt weird) and PAIN (pain). At the time of the report, DIZZINESS (very dizzy), ASTHENIA (weak), EYE PAIN (eyes hurt), VISION BLURRED (sees blurred), HEADACHE (headache), CHILLS (chills), FEELING ABNORMAL (body felt weird) and PAIN (pain) outcome was unknown.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Hyperhidrosis, Malaise
Clinical narrative: sweat; headaches; running a low grade fever; chills; body aches/muscle aches; not feeling well/"feeling crumby"; would feel would bad once it wore off; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well/"feeling crumby"), FEELING ABNORMAL (would feel would bad once it wore off), HYPERHIDROSIS (sweat), VACCINATION SITE PAIN (sore arm) and HEADACHE (headaches) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Medical history was not provided.).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 01-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (not feeling well/"feeling crumby"), FEELING ABNORMAL (would feel would bad once it wore off) and MYALGIA (body aches/muscle aches). On 02-Apr-2021, the patient experienced HYPERHIDROSIS (sweat), HEADACHE (headaches), PYREXIA (running a low grade fever) and CHILLS (chills). At the time of the report, MALAISE (not feeling well/"feeling crumby"), FEELING ABNORMAL (would feel would bad once it wore off), HYPERHIDROSIS (sweat), VACCINATION SITE PAIN (sore arm), HEADACHE (headaches), MYALGIA (body aches/muscle aches), PYREXIA (running a low grade fever) and CHILLS (chills) outcome was unknown. Not Provided          Treatment: Alternating Advil with Tylenol.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Added Reporter information.Added events : headache, low grade fever, chills, sweat.Treatment medication added.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: sweat; headaches; running a low grade fever; chills; body aches/muscle aches; not feeling well/"feeling crumby"; would feel would bad once it wore off; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling well/"feeling crumby"), FEELING ABNORMAL (would feel would bad once it wore off), HYPERHIDROSIS (sweat), VACCINATION SITE PAIN (sore arm) and HEADACHE (headaches) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Medical history was not provided.).   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 01-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (not feeling well/"feeling crumby"), FEELING ABNORMAL (would feel would bad once it wore off) and MYALGIA (body aches/muscle aches). On 02-Apr-2021, the patient experienced HYPERHIDROSIS (sweat), HEADACHE (headaches), PYREXIA (running a low grade fever) and CHILLS (chills). At the time of the report, MALAISE (not feeling well/"feeling crumby"), FEELING ABNORMAL (would feel would bad once it wore off), HYPERHIDROSIS (sweat), VACCINATION SITE PAIN (sore arm), HEADACHE (headaches), MYALGIA (body aches/muscle aches), PYREXIA (running a low grade fever) and CHILLS (chills) outcome was unknown. Not Provided          Treatment: Alternating Advil with Tylenol.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Added Reporter information.Added events : headache, low grade fever, chills, sweat.Treatment medication added.